| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10799843 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2016 | 38 Pages |
Abstract
Rhamnetin acts as a promising sensitizer to chemotherapy and may be a novel approach to overcome the MDR process of HCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Hui Jia, Qian Yang, Tao Wang, Yu Cao, Qi-yu Jiang, Hong-da Ma, Hui-wei Sun, Ming-xiao Hou, Yong-ping Yang, Fan Feng,